alprazolam has been researched along with Recrudescence in 27 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with panic disorder plus agoraphobia had 8 weeks of drug treatment (alprazolam or placebo) plus psychological treatment (exposure or relaxation)." | 9.07 | Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. ( Başoğlu, M; Brewin, CR; Kiliç, C; Marks, IM; Swinson, RP, 1994) |
| "This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation." | 9.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
| "The authors investigated whether cognitive behavioral treatment could facilitate discontinuation of alprazolam therapy and maintenance of drug abstinence among panic disorder patients treated with alprazolam doses sufficient to suppress spontaneous panic attacks." | 9.07 | Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1994) |
| "In a previous paper the authors reported survival data for 20 panic disorder patients whose therapeutic doses of alprazolam were tapered by one of two methods: slow, flexible drug taper with supportive medical management or the same taper procedure carried out concurrently with cognitive behavior therapy." | 7.69 | Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1995) |
| "This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule." | 7.68 | Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990) |
| "Panic disorder is a chronic illness with only some degree of spontaneous recovery." | 6.67 | Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993) |
| "Patients with panic disorder plus agoraphobia had 8 weeks of drug treatment (alprazolam or placebo) plus psychological treatment (exposure or relaxation)." | 5.07 | Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. ( Başoğlu, M; Brewin, CR; Kiliç, C; Marks, IM; Swinson, RP, 1994) |
| "This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation." | 5.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
| " The present study provided systematic data from a double blind comparison of maintenance therapy (up to 8 months) of panic disorder with or without agoraphobia with alprazolam, imipramine, or placebo in 181 patients who had responded to the same regimen in a randomized 8-week treatment trial." | 5.07 | Maintenance drug therapy of panic disorder. ( Ayuso, JL; Cassano, GB; Curtis, GC; Massana, J; Perugi, G; Udina, C, 1993) |
| "The authors investigated whether cognitive behavioral treatment could facilitate discontinuation of alprazolam therapy and maintenance of drug abstinence among panic disorder patients treated with alprazolam doses sufficient to suppress spontaneous panic attacks." | 5.07 | Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1994) |
| "Forty-eight patients with panic disorder completing 8 months of maintenance treatment with alprazolam (mean dose, 5." | 5.07 | Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. ( Rickels, K; Schweizer, E; Weiss, S; Zavodnick, S, 1993) |
| "In a previous paper the authors reported survival data for 20 panic disorder patients whose therapeutic doses of alprazolam were tapered by one of two methods: slow, flexible drug taper with supportive medical management or the same taper procedure carried out concurrently with cognitive behavior therapy." | 3.69 | Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. ( Bruce, TJ; Gregg, SF; Nuzzarello, A; Spiegel, DA, 1995) |
| "This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule." | 3.68 | Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990) |
| "Panic disorder is a chronic illness with only some degree of spontaneous recovery." | 2.67 | Discontinuation reactions to alprazolam in panic disorder. ( Pecknold, JC, 1993) |
| "Rebound anxiety and withdrawal symptoms were identified in a substantial minority of patients." | 2.67 | Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. ( Cook, B; Garvey, MJ; Noyes, R; Suelzer, M, 1991) |
| "No serious or life-threatening withdrawal symptoms were reported, but distinct, transient, mild to moderate withdrawal syndrome occurred in 35% of the alprazolam-treated group and in none of the placebo-treated group." | 2.66 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. ( Kuch, K; Lewis, CP; Pecknold, JC; Swinson, RP, 1988) |
| " Finally, the authors discuss general issues concerning the relapse of patients upon drug discontinuation, the long-term use of benzodiazepines, and other important issues concerning the use of these agents for the treatment of social phobia." | 2.39 | Treatment of social phobia with benzodiazepines. ( Davidson, JR; Potts, NL; Tupler, LA, 1994) |
| "Alprazolam treatment was tapered in 17 panic patients at a rate of 10% of the starting dose every 3 days." | 1.27 | Discontinuation of alprazolam treatment in panic patients. ( Campeas, R; Davies, SO; Fyer, AJ; Goetz, D; Gorman, JM; Klein, DF; Levin, A; Liebowitz, MR, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 16 (59.26) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nivy, R | 1 |
| Segev, G | 1 |
| Rimer, D | 1 |
| Bruchim, Y | 1 |
| Aroch, I | 1 |
| Mazaki-Tovi, M | 1 |
| Dueñas-Laita, A | 1 |
| Ruiz-Muñoz, P | 1 |
| Armentia, A | 1 |
| Pinacho, F | 1 |
| Martín-Armentia, B | 1 |
| Roberson-Nay, R | 1 |
| Latendresse, SJ | 1 |
| Kendler, KS | 1 |
| Klein, E | 2 |
| Andersch, S | 1 |
| Hetta, J | 1 |
| Uhlenhuth, EH | 1 |
| Leon, AC | 1 |
| Matuzas, W | 1 |
| Chouinard, G | 1 |
| Labonte, A | 1 |
| Fontaine, R | 1 |
| Annable, L | 1 |
| Bruce, TJ | 2 |
| Spiegel, DA | 2 |
| Gregg, SF | 2 |
| Nuzzarello, A | 2 |
| Romach, M | 1 |
| Busto, U | 1 |
| Somer, G | 1 |
| Kaplan, HL | 1 |
| Sellers, E | 1 |
| Başoğlu, M | 1 |
| Marks, IM | 1 |
| Kiliç, C | 1 |
| Brewin, CR | 1 |
| Swinson, RP | 2 |
| Colin, V | 1 |
| Stolk, J | 1 |
| Lenox, RH | 1 |
| Davidson, JR | 1 |
| Tupler, LA | 1 |
| Potts, NL | 1 |
| Curtis, GC | 1 |
| Massana, J | 1 |
| Udina, C | 1 |
| Ayuso, JL | 1 |
| Cassano, GB | 1 |
| Perugi, G | 1 |
| Pecknold, JC | 2 |
| Ballenger, JC | 1 |
| Pecknold, J | 1 |
| Rickels, K | 2 |
| Sellers, EM | 1 |
| Schweizer, E | 1 |
| Weiss, S | 1 |
| Zavodnick, S | 1 |
| Fava, GA | 1 |
| Rosenbaum, JF | 1 |
| Pollack, MH | 1 |
| Pollock, RA | 1 |
| McCann, UD | 1 |
| Ricaurte, GA | 1 |
| Ross, CA | 1 |
| Noyes, R | 1 |
| Garvey, MJ | 1 |
| Cook, B | 1 |
| Suelzer, M | 1 |
| Haque, W | 1 |
| Watson, DJ | 1 |
| Bryant, SG | 1 |
| Roy-Byrne, PP | 1 |
| Dager, SR | 1 |
| Cowley, DS | 1 |
| Vitaliano, P | 1 |
| Dunner, DL | 1 |
| Fyer, AJ | 2 |
| Liebowitz, MR | 2 |
| Gorman, JM | 2 |
| Campeas, R | 2 |
| Levin, A | 2 |
| Sandberg, D | 1 |
| Fyer, M | 1 |
| Hollander, E | 1 |
| Papp, L | 1 |
| Goetz, D | 2 |
| Kuch, K | 1 |
| Lewis, CP | 1 |
| Davies, SO | 1 |
| Klein, DF | 1 |
3 reviews available for alprazolam and Recrudescence
| Article | Year |
|---|---|
Treatment of social phobia with benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Humans; Phob | 1994 |
Medication discontinuation in panic disorder.
Topics: Alprazolam; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Admini | 1993 |
Clinical issues in the long-term treatment of panic disorder.
Topics: Age Factors; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Child; Cognitive B | 1996 |
14 trials available for alprazolam and Recrudescence
| Article | Year |
|---|---|
A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Dise | 2019 |
Successful treatment of chronic drug-resistant urticaria with alprazolam.
Topics: Alprazolam; Chronic Disease; Cyproheptadine; Humans; Platelet Membrane Glycoproteins; Receptors, G-P | 2009 |
A 15-year follow-up study of patients with panic disorder.
Topics: Activities of Daily Living; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Sec | 2003 |
Psychopathology of panic attacks in panic disorder.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Cognition; Humans; I | 2006 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C | 1983 |
Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.
Topics: Adult; Agoraphobia; Alprazolam; Arousal; Combined Modality Therapy; Desensitization, Psychologic; Fe | 1994 |
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu | 1994 |
Maintenance drug therapy of panic disorder.
Topics: Agoraphobia; Alprazolam; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imipramine; | 1993 |
Discontinuation reactions to alprazolam in panic disorder.
Topics: Agoraphobia; Alprazolam; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Adminis | 1993 |
Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
Topics: Adult; Alprazolam; Ambulatory Care; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Ad | 1994 |
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Topics: Adult; Alprazolam; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admi | 1993 |
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male | 1991 |
Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
Topics: Adult; Alprazolam; Anxiety; Diazepam; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged; | 1989 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Drug Administration Schedule; Fear; | 1988 |
10 other studies available for alprazolam and Recrudescence
| Article | Year |
|---|---|
A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.
Topics: Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Diagnostic and Statistical Man | 2012 |
The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Delay | 2002 |
Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
Topics: Adult; Alprazolam; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Administration Sche | 1995 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 1995 |
Anxiety sensitivity.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Benzodiazepines; Cognitive Behavioral Therapy; Combined | 1996 |
MDMA ("ecstasy") and panic disorder: induction by a single dose.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Alprazolam; Anxiety Disorders; Arousal; | 1992 |
Adverse reaction to generic alprazolam.
Topics: Alprazolam; Drugs, Generic; Female; Humans; Middle Aged; Panic Disorder; Recurrence | 1991 |
Death following suspected alprazolam withdrawal seizures: a case report.
Topics: Alprazolam; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Middle Aged; Psychoses, Substance-I | 1990 |
Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study.
Topics: Adult; Alprazolam; Clonidine; Female; Humans; Male; Phobic Disorders; Prospective Studies; Psychiatr | 1988 |
Discontinuation of alprazolam treatment in panic patients.
Topics: Acute Disease; Adult; Alprazolam; Anxiety Disorders; Dizziness; Fear; Female; Humans; Male; Middle A | 1987 |